Center for Drug Discovery in the News
The Cancer Prevention and Research Institute of Texas has awarded a grant to Baylor College of Medicine to establish a Preclinical Candidate Discovery Core. (more)
A fusion gene—formed by two separate parental genes through abnormal chromosomal rearrangement—may provide a clue and a marker for identifying a sub-group of the most common form of ovarian cancer, said researchers from Baylor College of Medicine in a report that appears in PNAS. (more)
Baylor College of Medicine's Center for Drug Discovery, have been awarded a $2.8 million grant by the Welch Foundation to support their work toward discovering next-generation drugs. (more)
Dr. Martin M. Matzuk, director of the Center for Drug Discovery and vice chair of pathology & immunology at Baylor College of Medicine, is elected to the National Academy of Sciences. (more)
Quest for male contraceptive may start with small molecule that has been characterized through a collaboration between the laboratories of Dr. Martin Matzuk (Baylor College of Medicine) and Dr. Jay Bradner (Dana-Farber Cancer Institute). (more)
